FENTANYL CITRATE injection, solution

Land: Bandaríkin

Tungumál: enska

Heimild: NLM (National Library of Medicine)

Virkt innihaldsefni:

FENTANYL CITRATE (UNII: MUN5LYG46H) (FENTANYL - UNII:UF599785JZ)

Fáanlegur frá:

Cantrell Drug Company

Stjórnsýsluleið:

INTRAVENOUS

Gerð lyfseðils:

PRESCRIPTION DRUG

Leyfisstaða:

unapproved drug other

Vara einkenni

FENTANYL CITRATE - FENTANYL CITRATE INJECTION, SOLUTION
CANTRELL DRUG COMPANY
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
FENTANYL CITRATE 20 MCG/ML IN 0.9% SODIUM CHLORIDE 30 ML PCA VIAL,
NON-MEDNET
FENTANYL CITRATE
fentanyl citrate injection, solution
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:52533-0 25
ROUTE OF ADMINISTRATION
INTRAVENOUS
DEA SCHE DULE
CII
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
FENTANYL CITRATE (UNII: MUN5LYG46 H) (FENTANYL - UNII:UF59 9 78 5JZ)
FENTANYL
20 ug in 1 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
SO DIUM CHLO RIDE (UNII: 451W47IQ8 X)
9 mg in 1 mL
WA TER (UNII: 0 59 QF0 KO0 R)
OTHER INGREDIENTS
INGREDIENT KIND
INGREDIENT NAME
QUANTITY
Cantrell Drug Company
May co ntain
HYDRO CHLO RIC ACID (UNII: QTT1758 2CB)
May co ntain
SO DIUM HYDRO XIDE (UNII: 55X0 4QC32I)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:52533-0 25-10
30 mL in 1 SYRINGE, GLASS
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 8 /13/20 14
LABELER -
Cantrell Drug Company (035545763)
Revised: 8/2014